We have isolated RNA polymerase from Mycobacterium smegmatis and established conditions for specific transcription initiation in vitro. The M. smegmatis enzyme has a strong dependence on supercoiling of the DNA substrate for transcription from mycobacterial promoters. We also show that RNA polymerase is the target for rifampicin, and that this antibiotic specifically inhibits the transition from synthesis of short oligoribonucleotides to full‐length transcripts. RNA polymerase isolated from a rifampicin‐resistant mutant of M. smegmatis is less sensitive to rifampicin in vitro, confirming that one mechanism of rifampicin resistance in mycobacteria is through alteration of RNA polymerase. This in vitro transcription system provides a simple m...
A 24 : 1 (w/w) mixture of antibiotic rifampicin and a plant product piperine show remarkable growth ...
Transcriptional regulation following mycobacteriophage I3 infection has been investigated. For this ...
Rifampicin (Rif) is a first line drug used for tuberculosis treatment. However, the emergence of dru...
The startling increase in the occurrence of rifampicin (Rif) resistance in the clinical isolates of ...
RNA polymerase binding protein A (RbpA) was first discovered as a RNA polymerase binding protein fro...
Rifampicin and its derivatives are at the forefront of the current standard chemotherapeutic regimen...
Rifampicin and its derivatives are at the forefront of the current standard chemotherapeutic regimen...
The startling increase in the occurrence of rifampicin (Rif) resistance in the clinical isolates of ...
The protein MsRbpA from Mycobacterium smegmatis rescues RNA polymerase (RNAP) from the inhibitory ef...
Transcriptional regulation following mycobacteriophage I3 infection was investigated. For this purp...
RNA polymerase (nucleosidetriphosphate : RNA nucleotidyltransferase (DNA-dependent), EC 2.7.7.6) was...
Novel insertion and deletion mutants of RpoB that renderMycobacterium smegmatis RNA polymerase resis...
Rapid emergence of multi-drug resistance in Mycobacterium tuberculosis has necessitated the developm...
MsRbpA is an RNA polymerase (RNAP) binding protein from Mycobacterium smegmatis. According to previo...
MsRbpA is an RNA polymerase (RNAP) binding protein from Mycobacterium smegmatis. According to previo...
A 24 : 1 (w/w) mixture of antibiotic rifampicin and a plant product piperine show remarkable growth ...
Transcriptional regulation following mycobacteriophage I3 infection has been investigated. For this ...
Rifampicin (Rif) is a first line drug used for tuberculosis treatment. However, the emergence of dru...
The startling increase in the occurrence of rifampicin (Rif) resistance in the clinical isolates of ...
RNA polymerase binding protein A (RbpA) was first discovered as a RNA polymerase binding protein fro...
Rifampicin and its derivatives are at the forefront of the current standard chemotherapeutic regimen...
Rifampicin and its derivatives are at the forefront of the current standard chemotherapeutic regimen...
The startling increase in the occurrence of rifampicin (Rif) resistance in the clinical isolates of ...
The protein MsRbpA from Mycobacterium smegmatis rescues RNA polymerase (RNAP) from the inhibitory ef...
Transcriptional regulation following mycobacteriophage I3 infection was investigated. For this purp...
RNA polymerase (nucleosidetriphosphate : RNA nucleotidyltransferase (DNA-dependent), EC 2.7.7.6) was...
Novel insertion and deletion mutants of RpoB that renderMycobacterium smegmatis RNA polymerase resis...
Rapid emergence of multi-drug resistance in Mycobacterium tuberculosis has necessitated the developm...
MsRbpA is an RNA polymerase (RNAP) binding protein from Mycobacterium smegmatis. According to previo...
MsRbpA is an RNA polymerase (RNAP) binding protein from Mycobacterium smegmatis. According to previo...
A 24 : 1 (w/w) mixture of antibiotic rifampicin and a plant product piperine show remarkable growth ...
Transcriptional regulation following mycobacteriophage I3 infection has been investigated. For this ...
Rifampicin (Rif) is a first line drug used for tuberculosis treatment. However, the emergence of dru...